Ou Bai

10PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHumoural immunology and immunochemistryHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 18, 2026
Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS Lymphoma.

|Jan 09, 2026
Polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) primary prophylaxis significantly reduces the duration of neutropenia in non-Hodgkin's lymphoma patients treated with chemotherapy: a randomised trial (NCT05834751).

Bowen Wang, Luming Cao, Jia Li

|Sep 27, 2024
Time to lymphoma treatment within 24 months in 'watch and wait' follicular lymphoma is associated with inferior outcomes: A multicentre analysis.

Jing Liu, Fenghua Gao, Tingting Zhang

|May 16, 2024
Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.

Zhaoxia Li, Wei Guo, Yangzhi Zhao

|May 03, 2023
Clinical features and prognosis of double primary malignant neoplasms in patients with non-hodgkin lymphoma.

Zhumei Zhan, Wei Guo, Jia Li

|Jan 09, 2023
Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors.

Zhumei Zhan, Wei Guo, Xin Wan

Pageof 2

Frequent Collaborators

1 joint publications

Xinxing Huang

1 joint publications

Wei Guo

1 joint publications

Fei Sun

1 joint publications

Shuping Xu